Effective: 1st June to 31st December 2022.
Who should undergo a lung screening?
- People who are aged between 45 years to 75 years old and have been smoking for more than 20 years.
- Adults (male or female) who have family history of Lung Cancer.
- People with suspicious lung X-Rays should undergo the LDCT scan for further confirmation.
Stages of Lung Cancer
As we talk about lung cancer, it’s important for readers to know and to differentiate the stages of Lung Cancer which indicates the seriousness of the disease.
People with stage 1 lung cancer generally have the most promising outlook.
Current statistics suggest that anywhere from 70% to 92% of people with stage 1 non-small cell lung cancer (NSCLC) can expect to live at least 5 years following their diagnosis.1
Patients with late stage lung cancer (Stage 3-4), only between 5% to 15% of those diagnosed will live up to 5 years or more.1
Hence LCNM is encouraging people at risk of Lung Cancer to undergo lung screening to facilitate early detection and more effective treatment of lung cancer.
However, with newer and more effective treatment such as, New Technology in Radiotherapy, Targeted Therapy and Immunotherapy, many Lung Cancer patients live well beyond five years.
LCNM is also currently piloting the use of a new & technologically advanced, Artificial Intelligence X-Ray System together with Qualitas Health Clinics in the Klang Valley. This advanced X-Ray system is able to provide a highly detailed X-Ray image of the lungs and is capable of highlighting even small abnormalities on the X-Ray.
Patients with lung X-Ray abnormalities are thereafter recommended to undergo a Low-Dose CT (LDCT) scan to confirm the exact 3D position of the abnormality within the lungs. A consultant would then be able to explain the next course of action based on the LDCT findings.
GET YOUR LUNG SCREENING DONE NOW !
For those who are Interested on lung screening, please contact Qualitas Health or call/whatsapp +6012-500-7964 (Mon-Fri: 9.00am to 5.00pm, Sat: 9.00am to 12.00pm).
- Goldstraw P, Chansky K, Crowley J, et. al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39-51.
LCNM wished to thank AstraZeneca Malaysia Sdn. Bhd. for assisting and facilitating the Subsidised LDCT Screening Programme together with the use of Artificial Intelligence X-Ray with the relevant stakeholders.